Khakoo SI[au] - Search Results

Year	Number of Results
1994	1
1995	1
1996	2
1997	1
2000	2
2001	1
2002	2
2003	2
2004	1
2005	1
2006	2
2008	3
2009	2
2010	6
2011	7
2012	2
2013	6
2014	6
2015	6
2016	5
2017	7
2018	7
2019	14
2020	7
2021	6
2022	6
2023	9
2024	6

1

XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.

Fisher JG, Doyle ADP, Graham LV, Sonar S, Sale B, Henderson I, Del Rio L, Johnson PWM, Landesman Y, Cragg MS, Forconi F, Walker CJ, Khakoo SI, Blunt MD. Fisher JG, et al. Among authors: khakoo si. Leukemia. 2023 Oct;37(10):2036-2049. doi: 10.1038/s41375-023-01984-z. Epub 2023 Aug 1. Leukemia. 2023. PMID: 37528310 Free PMC article.

2

Harnessing natural killer cell effector function against cancer.

Blunt MD, Khakoo SI. Blunt MD, et al. Among authors: khakoo si. Immunother Adv. 2023 Dec 21;4(1):ltad031. doi: 10.1093/immadv/ltad031. eCollection 2024. Immunother Adv. 2023. PMID: 38223411 Free PMC article. Review.

3

NK cells: tuned by peptide?

Das J, Khakoo SI. Das J, et al. Among authors: khakoo si. Immunol Rev. 2015 Sep;267(1):214-27. doi: 10.1111/imr.12315. Immunol Rev. 2015. PMID: 26284480 Review.

4

Targeting KIR as a novel approach to improve CAR-NK cell function.

Graham LV, Fisher JG, Khakoo SI, Blunt MD. Graham LV, et al. Among authors: khakoo si. J Transl Genet Genom. 2023 Dec 5;7:230-235. doi: 10.20517/jtgg.2023.25. J Transl Genet Genom. 2023. PMID: 38229912 Free PMC article.

5

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges.

Phoolchund AGS, Khakoo SI. Phoolchund AGS, et al. Among authors: khakoo si. Cancers (Basel). 2024 Jan 6;16(2):259. doi: 10.3390/cancers16020259. Cancers (Basel). 2024. PMID: 38254750 Free PMC article. Review.

6

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.

Abbas N, Culver EL, Thorburn D, Halliday N, Crothers H, Dyson JK, Phaw A, Aspinall R, Khakoo SI, Kallis Y, Smith B, Patanwala I, McCune A, Chimakurthi CR, Hegade V, Orrell M, Jones R, Mells G, Thain C, Thain RM, Jones D, Hirschfield G, Trivedi PJ. Abbas N, et al. Among authors: khakoo si. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1561-1570.e13. doi: 10.1016/j.cgh.2022.07.038. Epub 2022 Aug 9. Clin Gastroenterol Hepatol. 2023. PMID: 35961518 Free article.

7

Immunotherapy for hepatocellular carcinoma: a "CRAFITY" approach to patient stratification.

Khakoo SI. Khakoo SI. Hepatobiliary Surg Nutr. 2022 Apr;11(2):327-329. doi: 10.21037/hbsn-2021-32. Hepatobiliary Surg Nutr. 2022. PMID: 35464263 Free PMC article. No abstract available.

8

Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy.

Kumar N, Khakoo SI. Kumar N, et al. Among authors: khakoo si. HLA. 2018 Apr 17. doi: 10.1111/tan.13275. Online ahead of print. HLA. 2018. PMID: 29667374 Review.

9

KIR/HLA interactions and pathogen immunity.

Jamil KM, Khakoo SI. Jamil KM, et al. Among authors: khakoo si. J Biomed Biotechnol. 2011;2011:298348. doi: 10.1155/2011/298348. Epub 2011 May 19. J Biomed Biotechnol. 2011. PMID: 21629750 Free PMC article. Review.

10

Immunotherapy for hepatocellular carcinoma: Current and future.

Johnston MP, Khakoo SI. Johnston MP, et al. Among authors: khakoo si. World J Gastroenterol. 2019 Jun 28;25(24):2977-2989. doi: 10.3748/wjg.v25.i24.2977. World J Gastroenterol. 2019. PMID: 31293335 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year